All Releases
 |
SIGA to Discuss Fourth Quarter and Year-End 2009 Results of Operations on March 10, 2010
Mar 5, 2010
|
9.7 KB |
|
| |
NEW YORK, Mar 5, 2010 (GlobeNewswire via COMTEX News Network) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight bio-warfare pathogens, announced today that it will report fourth quarter and full-year 2009 results on Wednesday, March 10, 2010.
Management will host a conference c...
|
|
SIGA to Participate at RBC Capital Markets and Cowen & Company Healthcare Conferences
Mar 1, 2010
|
11.9 KB |
|
| |
NEW YORK, Mar 1, 2010 (GlobeNewswire via COMTEX News Network) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, today announced that management will present at the following investor conferences in March 2010.
Event: RBC Capital Markets Conference Biodefen...
|
|
SIGA Awarded a $2.8 Million DoD Contract With Additional Options for the Development of a Broad Spectrum Antiviral Drug
Feb 25, 2010
|
14.2 KB |
|
| |
NEW YORK, Feb 25, 2010 (GlobeNewswire via COMTEX News Network) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, today announced it was awarded a $2.8 million contract with options for up to $9.9 million from the Department of Defense's Transformational Medica...
|
|
Israel Taps SIGA Technologies' ST-246(R) to Combat Smallpox in Simulated Bioterror Attack
Jan 19, 2010
|
12.8 KB |
|
| |
NEW YORK, Jan 19, 2010 (GlobeNewswire via COMTEX News Network) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, today announced that it was contacted to arrange an emergency mock acquisition of its lead drug candidate and smallpox antiviral, ST-246(R) (Tecovi...
|
|
SIGA Technologies, Inc. Announces Close of $20 Million Common Stock Offering
Dec 14, 2009
|
12.3 KB |
|
| |
NEW YORK, Dec 14, 2009 (GlobeNewswire via COMTEX News Network) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, today announced the closing of its offering of 2,725,339 shares of common stock to a select group of institutional investors at a price of $7.35 pe...
|
|
SIGA to Hold Conference Call on Monday, December 14, 2009 at 8:30 A.M. ET
Dec 11, 2009
|
12.0 KB |
|
| |
NEW YORK, Dec 11, 2009 (GlobeNewswire via COMTEX News Network) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, today announced that it will hold a conference call to discuss the Biomedical Advanced Research & Development Authority's (BARDA) amendment today t...
|
|
SIGA Technologies, Inc. Raises $20.0 Million in a Common Stock Offering
Dec 10, 2009
|
12.2 KB |
|
| |
NEW YORK, Dec 10, 2009 (GlobeNewswire via COMTEX News Network) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, announced today that it has entered into definitive agreements with investors for the sale of 2,725,339 shares of common stock at a price of $7.35 ...
|
|
SIGA Technologies Reports Operating Results for the Third Quarter of 2009
Nov 9, 2009
|
12.2 KB |
|
| |
NEW YORK, Nov 9, 2009 (GlobeNewswire via COMTEX News Network) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, today announced its results of operations for the third quarter of 2009.
The Company recognized revenues of $3.9 million and $9.9 million for th...
|
|
SIGA Presents Update on ST-246 Development to the World Health Organization
Nov 5, 2009
|
11.8 KB |
|
| |
NEW YORK, Nov 5, 2009 (GlobeNewswire via COMTEX News Network) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight bio-warfare pathogens, today announced that Dr. Dennis E. Hruby, SIGA's Chief Scientific Officer, presented SIGA's progress in developing its lead drug candidate, ST-246,...
|
|
SIGA Technologies to Discuss Third Quarter 2009 Results of Operations on November 9, 2009
Nov 2, 2009
|
9.6 KB |
|
| |
NEW YORK, Nov 2, 2009 (GlobeNewswire via COMTEX News Network) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight bio-warfare pathogens, plans to announce its third quarter 2009 results in a press release that will be issued on Monday November 9, 2009. A conference call and simultane...
|
|
SIGA Technologies Files $100 Million Shelf Registration
Oct 30, 2009
|
12.2 KB |
|
| |
NEW YORK, Oct 30, 2009 (GlobeNewswire via COMTEX News Network) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, announced the filing with the Securities and Exchange Commission (the "SEC") of a shelf registration statement on Form S-3 with respect to its comm...
|
|
$1.6 Million NIH Cooperative Agreement Supports SIGA Broad Spectrum Antiviral Research
Sep 29, 2009
|
12.4 KB |
|
| |
NEW YORK, Sep 29, 2009 (GlobeNewswire via COMTEX News Network) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, today announced the receipt of a $1.6 million research project cooperative agreement from the National Institutes of Health ("NIH") to accelerate t...
|
|
ST-246 Used to Treat Complications From Exposure to Recombinant Vaccinia Virus
Sep 15, 2009
|
11.9 KB |
|
| |
NEW YORK, Sep 15, 2009 (GlobeNewswire via COMTEX News Network) -- SIGA Technologies Inc. (Nasdaq:SIGA) announced that its smallpox antiviral drug, ST-246, has been used to treat a Pennsylvania patient suffering from complications due to exposure to a live vaccinia-vectored rabies vaccine. Following consultation with the Pennsylvania Health Departme...
|
|
SIGA Technologies Inc. Approved for NASDAQ Global Market Listing
Sep 3, 2009
|
11.1 KB |
|
| |
NEW YORK, Sep 3, 2009 (GlobeNewswire via COMTEX News Network) -- SIGA Technologies Inc. (Nasdaq:SIGA) announced today that its common stock listing will transfer from the NASDAQ Capital Market to the NASDAQ Global Market. The transfer will be effective at the opening of business on Thursday, September 3, 2009 and the Company's common stock will con...
|
|
SIGA Technologies Receives a $3 Million Research Grant From the National Institutes of Health
Sep 2, 2009
|
12.7 KB |
|
| |
NEW YORK, Sep 2, 2009 (GlobeNewswire via COMTEX News Network) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight bio-warfare pathogens, today announced that it has received a Phase II grant of approximately $3 million from the National Institutes of Health (NIH), to continue explori...
|
|
SIGA Technologies Reports Operating Results for the Second Quarter of 2009
Aug 6, 2009
|
12.6 KB |
|
| |
NEW YORK, Aug 6, 2009 (GlobeNewswire via COMTEX News Network) -- SIGA Technologies, Inc. (NASDAQ: SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, today announced its results of operations for the second quarter of 2009.
The Company recognized revenues of $4.0 million and $5.9 million for ...
|
|
SIGA Technologies Reschedules Quarterly Update Call to 10:30 AM EDT On August 6, 2009
Aug 3, 2009
|
8.8 KB |
|
| |
NEW YORK, Aug 3, 2009 (GlobeNewswire via COMTEX News Network) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight bio-warfare pathogens, has rescheduled its quarterly update call to 10:30 am EDT on Thursday, August 6, 2009 from 9:30 am EDT on that same day. Dial-in access to the call...
|
|
SIGA Technologies to Announce Second Quarter 2009 Results of Operations On August 6, 2009
Jul 27, 2009
|
9.6 KB |
|
| |
NEW YORK, Jul 27, 2009 (GlobeNewswire via COMTEX News Network) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight bio-warfare pathogens, plans to announce its second quarter 2009 results in a press release that will be issued on Thursday, August 6, 2009 before the market open. The C...
|
|
SIGA Reaches Next Stage in BARDA's RFP Bidding Process
Jun 29, 2009
|
12.5 KB |
|
| |
NEW YORK, Jun 29, 2009 (GlobeNewswire via COMTEX News Network) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, announced today that its response to the Department of Health and Human Services' (HHS) request for proposal for 1.7 million courses of a smallpox ...
|
|
SIGA Technologies, Inc. to be Added to the Russell 3000(r) and Russell Global(r) Indices
Jun 26, 2009
|
12.0 KB |
|
| |
NEW YORK, Jun 26, 2009 (GlobeNewswire via COMTEX News Network) -- SIGA Technologies, Inc. (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight biowarfare pathogens, announced today that it will be added to the Russell 3000(r) and the Russell Global(r) Indices, following Russell Investment Group's annual reconst...
|
|
|
